Additionally, high expression levels of FGFR2 and FGF7 have been associated with increased sensitivity to FGFR inhibitors in fusion-gene-positive rhabdomyosarcoma cell lines [62]. The gene discussed is FGFR2; the disease is rhabdomyosarcoma.